Xcell Biosciences Inc. (Xcellbio), a technology company focused on cell and gene therapy manufacturing applications, and AmplifyBio, a contract development and manufacturing organization, have launched a partnership designed to streamline and improve the manufacturing process for engineered T-cell receptor (TCR) therapies targeting solid tumors.   “There is a pressing need for more effective and potent therapies, and we believe that working with the Xcellbio team and their unique AVATAR Foundr...